These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3447608)

  • 1. Urine iron excretion in beta-thalassemia trait.
    Camerini G; Voghenzi A; Kalapurackal M
    Boll Soc Ital Biol Sper; 1987 Apr; 63(4):317-21. PubMed ID: 3447608
    [No Abstract]   [Full Text] [Related]  

  • 2. [Findings in relation to serum and urinary iron in heterozygotic beta-thalassemia].
    Lodi G; Squarzoni G; Bariani MC; Fogli B; Masotti M; Musiari A; Bariani L
    G Clin Med; 1989 Apr; 70(4):263-6. PubMed ID: 2767366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of iron "status" in heterozygote beta-thalassemia. Indications and counterindications for martial treatment].
    Soffritti E; Bernardoni R; Ferrari R; Dall'Ara G; Farina F; Pelizzola D
    Riv Eur Sci Med Farmacol; 1988 Jun; 10(3):209-18. PubMed ID: 3274710
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron deficiency in beta-heterozygous thalassaemia.
    Saraya AK; Kumar R; Kailash S; Sehgal AK
    Indian J Med Res; 1984 Jan; 79():68-75. PubMed ID: 6724654
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron excretion in thalassemia children treated with deferoxamin methansulfonat: intravenous drip compared to the subcutaneous routes.
    Hathirat P; Areekul S; Isarangkura P; Chantachum Y
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():121-4. PubMed ID: 2732632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thalassemia trait in the pediatric age and body iron status].
    Abreu de Miani MS; Calvo EB; Sanchís ME; Peñalver JA
    Sangre (Barc); 1986; 31(1):1-6. PubMed ID: 3704880
    [No Abstract]   [Full Text] [Related]  

  • 8. Ascorbic acid and iron excretion in a thalassemic child.
    Hathirat P; Areekul S; Pleehachinda R; Tuntawiroon M
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):274. PubMed ID: 6635769
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of free erythrocyte protoporphyrin in thalassemic trait].
    Vayá A; Mira Y; Miralles F; Aznar J
    Sangre (Barc); 1989 Feb; 34(1):47-9. PubMed ID: 2711285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron status and anemia in thalassemic Sardinian carriers.
    Pardini S; Dore F; Oggiano L; Bonfigli S; Pacifico S; Campus S; Longinotti M
    Haematologica; 1986; 71(1):17-9. PubMed ID: 3084350
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH; Iskandar W; Keng KL; Odang O
    Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heterozygote beta-microcythemic children in Iesi. Statistical findings and health prospects].
    Bini PL; Beccaceci P; Carotti G; Binci MC
    Minerva Med; 1983 Dec; 74(49-50):2921-5. PubMed ID: 6664585
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythrocyte zincprotoporphyrin (ZPP) in subjects with heterozygote beta-thalassemia, acquired non-microcytic anemias and iron deficiency.
    Cocuzza S; Avola G
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2171-8. PubMed ID: 6525276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron status in Sicilian subjects with beta-thalassemia trait.
    Musumeci S; Romeo MA; Di Gregorio F; Testa R; Schiliro' G
    Haematologica; 1985; 70(1):1-5. PubMed ID: 3924751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance and evaluation of red cell indices obtained with semi-automatic cell counters during the screening of heterozygote beta-thalassemia].
    Cocuzza S; Avola G; Rosella A
    Minerva Med; 1983 Apr; 74(18):1017-20. PubMed ID: 6678392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative relation between transferrin and total iron fixation capacity in patients carrying heterozygous A2 and F thalassemia].
    Llopis R; Laiz B; Cubillo P; Mira Y
    Rev Clin Esp; 1986 Jan; 178(1):11-2. PubMed ID: 3961228
    [No Abstract]   [Full Text] [Related]  

  • 17. The iron status of Italian subjects with beta-thalassemia trait.
    Fargion S; Taddei MT; Cappellini MD; Piperno A; Fiorelli G
    Acta Haematol; 1982; 68(2):109-14. PubMed ID: 6812365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-thalassaemia in Cuba.
    de la Torre E; Hernandez P; Martinez G; Srarch E; Colombo B
    Haematologia (Budap); 1974; 8(1-4):71-9. PubMed ID: 4461439
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of fetal hemoglobin among Israel families with beta-thalassemia.
    Rachmilewitz EA; Huisman TH; Schroeder WA
    Isr J Med Sci; 1973; 9(9):1464-8. PubMed ID: 4775133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.